{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:09:14Z","timestamp":1778216954094,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Extramedullary relapse of acute lymphoblastic leukemia (ALL) is usually associated with poor prognosis. Chimeric antigen receptor T cell (CAR-T cell) therapy followed by allogeneic hematopoietic stem cell transplantation is beneficial for relapsed\/refractory (r\/r) B cell acute lymphoblastic leukemia (B-ALL). Here, we report a B-ALL patient with extramedullary relapse involving several organs, including multiple lymph nodes and the breast, kidney, uterus and pancreas. After treatment with CAR-T cell therapy, positron emission tomography\/computed tomography (PET\/CT) revealed that she went into remission, with an almost undetectable tumor mass. She subsequently received unrelated cord blood transplantation (UCBT). Although she achieved minimal residual disease (MRD)-negative remission after UCBT for 5 months, she relapsed at the 6th month after UCBT. This patient achieved remission after subsequent interferon-\u03b1 treatment for two weeks but eventually died of severe pneumonia. This case highlights the possibility of unusual relapse sites after chemotherapy and that regular biopsy of the mass is not sufficient to assess the scope and location of recurrence. PET\/CT may be a useful tool to monitor the scope of extramedullary recurrence and follow-up remission. Further understanding of the pathology of extramedullary relapse is warranted to improve the management of such challenging presentations. This case suggests the efficacy of CAR-T cell therapy combined with UCBT in adult B-ALL patients with extramedullary relapse.<\/jats:p>","DOI":"10.3389\/fonc.2025.1508676","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T05:34:29Z","timestamp":1755668069000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Extramedullary relapse of acute lymphoblastic leukemia treated with a CAR-T cell therapy bridge to unrelated cord blood transplantation: a case report and review of the literature"],"prefix":"10.3389","volume":"15","author":[{"given":"Huibo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Hoelzer","year":"2016","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-017-0434-y","article-title":"Mutational profiling of acute lymphoblastic leukemia with testicular relapse","volume":"10","author":"Ding","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2021.399","article-title":"Outcomes of anti-CD19 CAR-T treatment of pediatric B-ALL with bone marrow and extramedullary relapse","volume":"54","author":"Wan","year":"2022","journal-title":"Cancer Res Treat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.145","article-title":"High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients","volume":"31","author":"Pan","year":"2017","journal-title":"Leukemia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-018-0593-5","article-title":"CD19 CAR-T cell therapy for relapsed\/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies","volume":"11","author":"Zhang","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25108","article-title":"Potent anti-leukemia activities of humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells in patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"93","author":"Cao","year":"2018","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.11.011","article-title":"Chimeric antigen receptor T cell therapy followed by unrelated cord blood transplantation for the treatment of relapsed\/refractory B cell acute lymphoblastic leukemia in children and young adults: Superior survival but relatively high post-transplantation relapse","volume":"28","author":"Sun","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879030","article-title":"Impact of consolidative unrelated cord blood transplantation on clinical outcomes of patients with relapsed\/refractory acute B lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1191382","article-title":"Analysis benefits of a second allo-HSCT after CAR-T cell therapy in patients with relapsed\/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant","volume":"14","author":"Cao","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13287-024-03835-9","article-title":"Single-cell sequencing of facial adipose tissue unveils FKBP5 as a therapeutic target for facial infiltrating lipomatosis","volume":"15","author":"Chen","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20148","DOI":"10.1038\/s41598-020-77186-9","article-title":"Preemptive interferon-\u03b1 treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12885-016-2910-0","article-title":"Complete response of extramedullary relapse in breast of acute T lymphoblastic leukemia after bone marrow transplantation to chemoradiotherapy: a case report and literature review","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4003","article-title":"Isolated renal relapse in a post-allogenic transplant adult patient with acute lymphoblastic leukemia","volume":"13","author":"Jimenez-Ochoa","year":"2022","journal-title":"J Med Cases"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24783","article-title":"Correlates of resistance and relapse during blinatumomab therapy for relapsed\/refractory acute lymphoblastic leukemia","volume":"92","author":"Aldoss","year":"2017","journal-title":"Am J Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2015.11.019","article-title":"Usefulness and pitfalls of F-18-FDG PET\/CT for diagnosing extramedullary acute leukemia","volume":"85","author":"Zhou","year":"2016","journal-title":"Eur J Radiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/mph.0000000000000447","article-title":"FDG-PET\/CT for detection of extramedullary disease in 2 pediatric patients with AML","volume":"38","author":"Matsui","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12085","article-title":"Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET","volume":"90","author":"Cribe","year":"2013","journal-title":"Eur J Haematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-018-0572-x","article-title":"A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia","volume":"11","author":"Weng","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0778-8","article-title":"Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Zhang","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40364-020-00193-5","article-title":"Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report","volume":"8","author":"Liu","year":"2020","journal-title":"biomark Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25274","article-title":"Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia","volume":"93","author":"Jacoby","year":"2018","journal-title":"Am J Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1027469","DOI":"10.1080\/2162402x.2015.1027469","article-title":"Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia","volume":"4","author":"Dai","year":"2015","journal-title":"Oncoimmunology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.02262","article-title":"Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL","volume":"39","author":"Shah","year":"2021","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-883710","article-title":"Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy","volume":"133","author":"Hay","year":"2019","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001466","article-title":"Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25582","article-title":"Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed\/refractory B-cell acute lymphoblastic leukemia: an open-label pragmatic clinical trail","volume":"94","author":"Jiang","year":"2019","journal-title":"Am J Hematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.02.006","article-title":"Sequential allogeneic HSCT after CAR-T therapy for relapsed\/refractory acute lymphoblastic leukemia patients: A long-term follow-up result","author":"Yang","year":"2025","journal-title":"J Adv Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40364-020-00247-8","article-title":"Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed\/refractory B-cell acute lymphoblastic leukemia: who? when? why","volume":"8","author":"Jiang","year":"2020","journal-title":"biomark Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000593","article-title":"Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy","volume":"3","author":"Shadman","year":"2019","journal-title":"Blood Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13776","article-title":"The dynamics of B-cell reconstitution post allogeneic hematopoietic stem cell transplantation: a real-world study","volume":"295","author":"Zhou","year":"2024","journal-title":"J Intern Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001021","article-title":"Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation","volume":"4","author":"Ando","year":"2020","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/cji.0000000000000233","article-title":"Donor-derived CAR-T cells serve as a reduced-intensity conditioning regimen for haploidentical stem cell transplantation in treatment of relapsed\/refractory acute lymphoblastic leukemia: case report and review of the literature","volume":"41","author":"Zhang","year":"2018","journal-title":"J Immunother"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1508676\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T05:34:30Z","timestamp":1755668070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1508676\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":34,"alternative-id":["10.3389\/fonc.2025.1508676"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1508676","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"article-number":"1508676"}}